Medical technology company Abanza has received FDA 510(k) clearance for QuadLock, a fixation system for ACL reconstruction.
The system can be used across several graft configurations that are commonly used in ACL procedures, such as quadriceps tendon, quadrupled semitendinosus/gracilis, and bone–patellar tendon–bone, according to a Jan. 27 news release from Abanza.
The knotless, bidirectional tension-adjustable fixation system displayed a 500% reduction in cyclic displacement compared to conventional fixation methods during biomechanical testing.
There are about 300,000 ACL reconstruction surgeries performed in the U.S. each year, the release said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
